Abstract:Introduction: Few studies have reported hepatic and cardiac iron overload in patients with end-stage renal disease (ESRD), and the current evidence regarding the prevalence is still scarce. Aim: This review aims to estimate the prevalence of hepatic and/or cardiac iron overload quantified by magnetic resonance imaging (MRI) in patients with ESRD who receive hemodialysis (HD), peritoneal dialysis (PD), or have undergone a kidney transplant. Methods: A systematic review with meta-analysis was conducted and reported in line with PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analysis) guidelines. MEDLINE and Embase bibliographic databases were searched using a comprehensive list of controlled vocabulary and keywords to identify relevant studies. All studies reporting the prevalence of hepatic and/or cardiac iron overload quantified by MRI in ESRD patients were considered. The Newcastle-Ottawa scale was used to assess the methodological quality of included studies. To investigate the heterogeneity between studies, random-effect meta-analyses for proportions were used. Results: The review comprised seven studies that included 339 patients. Using meta-analysis, the pooled prevalence of severe and mild to moderate hepatic iron overload quantified by MRI was 0.23 [95% CI: 0.08-0.43] and 0.52 [95% CI: 0.47-0.57], respectively. Only three studies included cardiac iron quantification, and none reported iron overload. Conclusions: This review has revealed a high prevalence of severe hepatic iron overload in patients with ESRD treated by HD. Further studies with a larger sample size are needed to determine the impact of iron overload on vital organs in patients with ESRD and guide future research in this understudied field. Proper use of iron chelation and continuous monitoring will help in the early detection of unsolicited complications; however, the low renal clearance of most iron chelators limits the options for treating iron excess in patients with ESRD.

The research progress of iron therapy in the treatment of anemia and brain iron deposition in patients with chronic kidney disease

Research Progress in Iron Biomarkers: a Review

The research and progress of brain MRI in end-stage renal disease

Concems of Intravenous Iron Therapy in Patients with Renal Anemia

Iron Therapies For Iron Deficiency In Chronic Kidney Disease: A Literature Review

Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents

Hepatic and cardiac iron overload quantified by magnetic resonance imaging in patients on hemodialysis: A systematic review and meta-analysis

Current and future chemical therapies for treating anaemia in chronic kidney disease

Theranostic Role of Iron Oxide Nanoparticle for Treating Renal Anemia: Evidence of Efficacy and Significance by MRI, Histology and Biomarkers

Iron Supplements Concomitant within Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitors in the Treatment of Chronic Kidney Disease Anemia

Advances in the Study of Early Iron Deficiency and Cognitive Brain Development—— Focusing on Brain Development from a Nutritional Perspective

Benefits and risks of essential trace elements in chronic kidney disease: a narrative review

Myocardial Iron Deficiency Quantification and Effective Cardiac Iron Management Strategy Exploration Evaluated by Cardiac T2* Mapping in End-Stage Renal Disease Patients.

Iron Deposition in Parkinson's Disease: A Mini-Review

Iron biology

Advance in Iron Metabolism, Oxidative Stress and Cellular Dysfunction in Experimental and Human Kidney Diseases

Anemia in Peritoneal Dialysis Patients; Iron Repletion, Current and Future Therapies

The role of iron transporters and regulators in Alzheimer's disease and Parkinson's disease: Pathophysiological insights and therapeutic prospects

Safety of Intravenous Iron – Cosmofer and Monofer Therapy in Peritoneal Dialysis and Non-Dialysis-Dependent Chronic Kidney Disease Patients

Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction

Brain Iron Dysregulation and Central Nervous System Diseases